Faculty News

Stanley Lipkowitz and Alexandra Zimmer answer breast cancer “Redditor” questions

Stanley Lipkowitz, M.D., Ph.D., Chief of the Women’s Malignancies Branch (WMB), and Alexandra Zimmer, M.D., Assistant Research Physician in WMB, recently answered questions about breast cancer during a Reddit “Ask Me Anything” (AMA). During the event, Drs. Lipkowitz and Zimmer discussed topics ranging from recent advances in breast cancer treatment to genetic and environmental factors that influence risk for disease.

Kenneth Aldape discusses importance of precise diagnosis in brain and spine tumors

Kenneth Aldape, M.D., Chief of the Laboratory of Pathology, recently discussed the importance of a precise diagnosis in the treatment of brain and spine tumors in an NCI-CONNECTions blog. In the blog, he shares how he’s using the latest technologies and techniques to provide more individualized care for patients.

Andre Nussenzweig elected to the National Academy of Medicine

Andre Nussenzweig, Ph.D., Chief of the Laboratory of Genome Integrity, has been elected to the National Academy of Medicine (NAM), one of the highest honors in the fields of health and medicine. Dr. Nussenzweig was elected to NAM for making seminal discoveries that speak to how cells maintain their own genome stability, allow chromosome fragility and license leukemogenesis at the hands of aberrant DNA repair.

Tim Greten discusses liver cancer with OncLive

Tim Greten, M.D., Deputy Chief of the Thoracic and GI Malignancies Branch, was recently interviewed by OncLive. In the interview, Dr. Greten discussed the role of the gut microbiome in antitumor immunity in liver cancer.

Amy LeBlanc discusses how dogs are helping cure childhood cancers

Amy LeBlanc, D.V.M., Director of the Center for Cancer Research’s Comparative Oncology Program, was recently featured in an Everyday Health article that discusses the importance of studying the connection between cancer in dogs and cancer in children. Dr. LeBlanc says, “By studying [dogs] in the context of clinical trials, it can advance new concepts and better treatment for humans and, potentially, for dogs as patients themselves.”

Steve Rosenberg receives Friends of Cancer Research Cancer Leadership Award

Steve Rosenberg, M.D., Ph.D., Chief of the Surgery Branch, recently received the Friends of Cancer Research Cancer Leadership Award. The award recognizes individuals who have been champions for cancer research and steadfast advocates for patients.

Lawrence Samelson receives Cancer Research Institute Coley Award

Lawrence Samelson, M.D., Chief of the Laboratory of Cellular and Molecular Biology, was named a recipient of the Cancer Research Institute’s 2019 William B. Coley Award for Distinguished Research in Basic and Tumor Immunology. The award recognizes scientists for their seminal discoveries in the fields of basic and tumor immunology.

Marston Linehan discusses kidney cancer breakthroughs with the Federal News Network podcast

Marston Linehan, M.D., Chief of the Urologic Oncology Branch, was recently featured on the Federal News Network podcast. During the episode, Dr. Linehan discussed how kidney cancer is not a single disease but rather a number of different cancers that all happen to occur in the kidney. He also discussed how human genetics research has led to advances in kidney cancer, such as discovering that there are multiple genes that cause 17 types of kidney cancer. He says that while there has been much progress, much work is still left to do.

The New York Times highlights the importance of physician-scientists

The New York Times recently posted an editorial highlighting the importance of physician-scientists in the medical field. The article cited several examples of discoveries made by physician-scientists that have changed the history of medicine, including the development of the HPV vaccine by Doug Lowy, M.D., Chief of the Laboratory of Cellular Oncology (LCO), and John Schiller, Ph.D., Deputy Chief of LCO.

Karlyne Reilly discusses childhood cancer on BioMedCentral

Karlyne M. Reilly, Ph.D., Senior Associate Scientist in the Pediatric Oncology Branch, recently wrote a blog for BioMedCentral. In the blog, Dr. Reilly addresses both the difficulties and the importance of accessing and collecting data from childhood cancer clinical trials and initiatives, such as MyPART, to help improve childhood cancer research in the future.

Breadcrumb